PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence

JAMA

2025-10-13
(Press-News.org)

About The Article: Artificial intelligence carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health care, including how AI is developed, evaluated, regulated, and implemented across clinical and business domains.  

This content is the result of JAMA Summit AI that was held in October 2024. Reflecting the multidisciplinary nature of JAMA Summit, this report features a diverse group of authors whose expertise spans clinical care, biomedical research, software engineering, data science, health policy, law, and industry innovation. 

JAMA Summit is an initiative of JAMA and the JAMA Network that convenes leaders from across sectors and around the world to discuss and debate critical issues in medicine, health, and health care.  

The JAMA Summit has two primary goals: first, to bring together thought leaders from diverse sectors to explore a key topic and identify actionable steps with immediate impact; and second, to spark broader conversations by publishing papers and multimedia content based on the themes that emerge from these discussions.  

Author Contact Information: The Corresponding Author of the JAMA Summit Report is Derek C. Angus, M.D., M.P.H. Allison Hydzik, Senior Director of Public Relations at UPMC and University of Pittsburgh Health Sciences, can assist with scheduling interviews. Allison can be reached at 412-559-2431 and hydzikam@upmc.edu.

Contact the JAMA Media Relations department at mediarelations@jamanetwork.org to obtain contact information for additional authors.  

About JAMA+ AI: For the latest research on AI from across the JAMA Network, visit the JAMA+ AI channel, which is celebrating its one-year anniversary this week. An email newsletter is available as well as a podcast.  

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.18490)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.18490?guestAccessKey=68dbcf5c-4a00-4e9d-881a-71bf2fade0d6&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101325

END



ELSE PRESS RELEASES FROM THIS DATE:

Large genetic study links cannabis use to psychiatric, cognitive and physical health

2025-10-13
University of California San Diego of Medicine researchers, in collaboration with the genetic testing company 23andMe, have identified regions of the human genome associated with cannabis use, uncovering new relationships with psychiatric, cognitive and physical health. The findings may inform the development of prevention and treatment strategies for cannabis use disorder. The study was published on October 13, 2025 in Molecular Psychiatry. “Cannabis is widely used, but its long-term effects ...

Social media use trajectories and cognitive performance in adolescents

2025-10-13
About The Study: This analysis found that both low and high increases in social media use throughout early adolescence were significantly associated with lower performance in specific aspects of cognitive function, supporting a prior finding that greater screen time was negatively but weakly associated with adolescent cognitive performance. Corresponding Author: To contact the corresponding author, Jason M. Nagata, MD, MSc, email jason.nagata@ucsf.edu. To access the embargoed study: Visit our For The Media ...

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults 

2025-10-13
A multi-center randomized controlled trial with critically ill adults aged 50 years and older admitted to intensive care units (ICUs) found that twice-daily slow-tempo music (60 to 80 beats per minute) did not shorten the duration of delirium or coma, or reduce delirium severity, pain or anxiety compared with a silence-track control. While the trial did not mitigate delirium, it showed a trend to fewer days with delirium/coma among patients who received at least seven doses of slow-tempo music. There was also a trend toward fewer days of delirium/coma among patients ...

AI models predict sepsis in children, allow preemptive care

2025-10-13
Sepsis, or infection causing life-threatening organ dysfunction, is a leading cause of death in children worldwide. In efforts to prevent this rare but critical condition, researchers developed and validated AI models that accurately identify children at high risk for sepsis within 48 hours, so that early preemptive care can be provided. These predictive models used routine electronic health record (EHR) data from the first four hours the child spent in the Emergency Department (ED), before organ dysfunction was present. The multi-center study, led by Elizabeth Alpern, MD, MSCE, from Ann & Robert H. Lurie Children’s Hospital of Chicago, is the first to use ...

Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes

2025-10-13
About The Study: In this comparative effectiveness study in veterans with diabetes, liraglutide, semaglutide, and dulaglutide initiators had similar risks for kidney and cardiovascular outcomes. Head-to-head randomized trials are needed to confirm these findings.  Corresponding Author: To contact the corresponding author, Srinivasan Beddhu, MD, email srinivasan.beddhu@hsc.utah.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.37297) Editor’s Note: Please see the article for additional information, including other authors, author ...

Antenatal corticosteroids and infectious diseases throughout childhood

2025-10-13
About The Study: In this cohort study, exposure to antenatal corticosteroids (ACS) was associated with increased risks of infections in full-term children until age 21. In preterm children born before 34 weeks’ gestation, no association between ACS and infections was found. To minimize the adverse effects of ACS treatment, more stringent criteria for ACS administration and better prediction tools for preterm birth are required.  Corresponding Author: To contact the corresponding author, Rebecca M. Reynolds, ...

New lab-grown human embryo model produces blood cells

2025-10-13
University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that replicate certain aspects of very early human development - including the production of blood stem cells. Human blood stem cells, also known as hematopoietic stem cells, are immature cells that can develop into any type of blood cell, including red blood cells that carry oxygen and various types of white blood cells crucial to the immune system. The embryo-like structures, which the scientists have named ‘hematoids’, are self-organising and start producing blood after around ...

Life after near death: Research reveals how to improve support for near-death experiencers

2025-10-13
Near-death experiences can have lasting, life-changing effects, and new University of Virginia School of Medicine research sheds light on the types of counseling and support that can best help people cope. The research, from UVA’s Division of Perceptual Studies, is believed to be the first to explore the most common and effective ways to assist people grappling with potentially profound changes to their world view. For most, near-death experiences, or NDEs, have a positive effect; the brush with ...

Illinois Chat is launched for campus community

2025-10-13
What began as a student project in 2023 will now serve a whole university community. Illinois Chat, an official artificial intelligence (AI) software tool of the University of Illinois Urbana-Champaign, has launched for the Fall 2025 semester and is available for anyone on campus. In partnership with the Office of the Chief Information Officer (CIO) and Illinois Computes, NCSA developed Illinois Chat to offer large language model (LLM) abilities to the entire campus community. This campus-developed tool allows users to create personalized LLM-based chatbots – ...

FAU receives $3M federal grant to prevent substance use in at-risk youth

2025-10-13
Florida Atlantic University has received a $3 million, five-year grant from the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the United States Department of Health and Human Services, to lead a transformative community initiative designed to prevent substance use among South Florida’s youth. The new program, “Rising Strong: Empowering Youth for Substance-Free Futures,” will implement evidence-based, trauma-informed prevention strategies to reach more than 3,000 youth across Palm Beach and Broward counties ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence
JAMA